Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-30

Clinical Trial Update: A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating LEO 35299 in psoriasis vulgaris has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEO 35299

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED | Results posted: 2013-12-30